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Inhibitors of protein-tyrosine kinases (TPKs) from the tyrphostms family induce termmal erythroid differentiation of mouse erythroleukemia 
(MEL) cells The most potent tyrphostin was found to be AC-568 which was therefore investigated in more detail. Just prior to differentiation 
the inhibition of tyrosine phosphorylation of a pp97 protem band was noted. We also found that AC-568 treatment Induces the appearance of 
a putative differentiation factor which could induce tyrphostm-independent differentiatron m untreated cells. Our study suggests that the inhibition 
of tyrosine phosphorylation by AC-568 leads to the production of differentiating factor(a) which induce the MEL cells to differentiate. 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Protein tyrosine kinases (PTKs) are involved in the 
regulation of cell proliferation and differentiation [I]. 
Oncogenic mutations in tyrosine kinases block normal 
cell differentiation and induce cellular transformation 
[l]. Furthermore, blockers of tyrosine kinase activity. 
such as tyrphostins [2] reverse the transformed pheno- 
type of SYC transformed cells [3] and strongly inhibit the 
growth of squamous cell carcinoma which overex- 
presses the EGF receptor [4]. In this communication we 
report on the potency of tyrphostins to induce differ- 
entiation of mouse erythroleukemia (MEL) cells, prob- 
ably due to its tyrosine kinase inhibitory activity. 
MEL cells have been widely used as a model for cell 
differentiation [6]. These cells can differentiate into 
erythroid cells in vitro in response to a number of com- 
pounds, including dimethyl sulfoxide [5] and hexameth- 
ylene-his-acetamide [6]. Herbimycin A, a non-selective 
PTK blocker has also been reported to induce differen- 
tiation of MEL cells [7]. Two other tyrosine kinase 
blockers, ST638 and genistein were found to induce 
differentiation of MEL cells only when added to the 
culture medium together with agents which damage 
DNA such as mitomycin C, or with inhibitors of topo- 
isomerases [8,9]. 
In this study we screened tyrphostins in an attempt 
to identify non-toxic PTK blockers which by themselves 
can induce MEL differentiation and which exhibit spec- 
ificity towards the MELC. 
*Corresponding author. Fax. (972) (2) 512 958 
2 1. Cell unti udture condmons 
MEL cells were cultured m RPM1 1640. supplemented with 10% 
fetal calf serum. 2 mM t.-glutamine. 100 units/ml penicillm and 10 
,@ml streptomycm. The cells were grown at 37°C in a humidified 
atmosphere, nith 5% CO,. 
The synthesis of tyrphostms IS described elsewhere [I l-l 31. 
2.3 .4s.\ur &or &I qowrh und er>hrold drffrrentmrion 
Cells (lx105/ml) were incubated with mcreasmg concentrations of 
tyrphostin in a final volume of 2.0 ml. As control we have used the 
medium containing identical concentrations of the tyrphostm solvent. 
DMSO The number of hve cells was measured by staining the cells 
with Trypan blue [15]. Erythroid differentration of the cells was eval- 
uated by benrtdme stammg as reported previously [16]. Tyrphostin 
was replenished every 72 h. Cells were centrifuged and resuspended 
in the desired concentration of the drug or the tyrphostin solvent as 
specified in the figures, 
Supernatants were prepared by sedimenting the cells (1,200 rpm). 
and the supernatant diluted with two volumes of fresh medium before 
addition to untreated cells. 
Exponentially growing MEL cells (approximately 7x105/ml), were 
treated with nontoxic levels of AG-568 for increasing periods of time. 
The cells vvere then washed twice with Hank’s buffered solution, and 
the pellet was resuspended with protem lysis buffer containing 10 mM 
Tris-HCI, pH 8.0. 50 mM NaCI, 5 mM EDTA. 30 mM Na pyro- 
phosphate, 50 mM NaF. I % Triton X-100,2 mM penylmethylsulfonyl 
fluoride. 100 KIU/ml aprotmm. 5pg/ml leupeptin and IOOfiM sodium 
vanadate. Cell lysates were prepared on ice for 1 h with short vortexing 
every IO min Cells lysates were cleared by centrifugation at 12.OOOxg 
for 30 min. The protein concentration of the supernatants was meas- 
ured using the Bio-Rad protein reagent. Cell lysates were boiled for 
6 mm m SDS gel sample buffer prior to electrophoresis. Sixty micro- 
grams of protein were loaded on each lane of 7.5% SDS poly- 
acrylamide gel, electrophoresed and blotted onto mtrocellulose paper 
(0.2 mm. Schleicher and Schuell Inc.) Protein blots were blocked 
overnight with 50 mM Tris-HCI. pH 7.5, 150 mM sodium chloride and 
0.05% Tween-20. 5% bovine serum albumin and 1% chicken egg albu- 
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min and then incubated for 2 h at room temperature with phosphoty- 
rosme antibodies (Zymed Inc.) in blocking solution. The filters were 
washed and incubated with peroxidase-protein A for 40 mm at room 
temperature, washed agam and subjected to ECL reaction (Amersham 
Inc.) and autoradiography. 
3. RESULTS 
3.1. Screening tyrphostins for their ability to induce dif- 
ferentiution of MEL cells 
Over 40 tyrphostins from different families [2, 12-141 
were examined for their ability to induce erythroid dif- 
ferentiation of MEL cells. Table I also shows for com- 
parison, the potency of the various tyrphostins tested 
for their potency to block EGFR kinase as compared 
to the blocking activity against p210h”-“” kinase in vitro, 
using previously described protocols [lo]. Only one tyr- 
phostin, AG568, (Table I) was found to be effective and 
to induce over 80% of the cells in the culture to differ- 
entiate. The onset of erythroid differentiation parallel 
to cell growth was followed for 15 days subsequent to 
AG568 application (Fig. 1). Between days 14 and 15 of 
the experiment an abrupt reduction of approximately 
40% in the benzidine positive cells was found concomi- 
Table I 
Screening of in vitro active tyrphostins for their ability to Induce 
differentiation of K562 and MEL cells 
Inducer for 
differentiation 
KS62 cells MEL cell! -___ 
Tyrphostms were screened for their potency to Inhibit EGFR kinase 
activity against poly Glu, Ala, Tyr [l l] and ~210’“.““’ kmase activity 
[14]. In parallel, the compounds were exammed for their potency to 
induce K562 differentiation [14] and differentiation of MEL cells as 
described in Section 2. 
B 
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Fig. 1, Kinetics of MEL cells differentiation induced by AG568. MEL 
cells (lx105/ml) were treated with 50 ,uM AC-568. At days 4 and 8. 
the cells were diluted with fresh medium and tyrophostin for their 
imtial concentration (lxlO’/ml). As control we treated the cells with 
medium that contained a comparable concentration of the tyrphostin 
solvent (0.1% DMSO). Part A is the kinetics of differentiation ex- 
pressed by the percent of hemoglobin containing cells, stamed with 
benzidme (B+ cells). Part B represents the growth kinetics. 
tantly with a 30% reduction of living cells. From day 5, 
cell differentiation was accompanied by growth arrest, 
and its degree correlates with the level of cell differentia- 
tion. Fig. 2 shows that treatment for four days with an 
AG568 concentration below 100 PM has no effect on 
cell proliferation or differentiation. On the other hand, 
after twelve days of treatment, differentiation levels 
reach 80% of the treated cells at 25-50 ,ffM AG568, 
concomitant to growth arrest. Growth arrest and differ- 
entiation follow a parallel doseeresponse curve with re- 
spect to AG568. The fact that AC568 concentrations 
below 100 ,uM had no effect on cell proliferation at day 
four of the experiment (Fig. 2A) and the correlation 
between the differentiation and growth arrest (Fig. 2B) 
suggest that the concentrations of AG568 effective in 
inducing differentiation are not toxic to the cells. Fig. 
3 shows the characteristic picture of AG568 treated cells 
compared to untreated cells. 
3.2. The effect of the supernatant of AGS68-treated cells 
on cell differentiation 
During our experiments, analyzing AG568 as differ- 
entiation inducer, we examined several types of treat- 
ments as schematically shown in Fig. 4. In the pro- 
261 
Volume 330. number 3 FEBS LETTERS 
does not induce cell differentiation. We also find that 
AG568 incubated in medium alone in the absence of 
cells, under identical conditions does not induce differ- 
entiation (data not shown). These results suggest that 
the differentiation is produced by MEL cells as a result 
from AG568 treatment. 
September 1993 
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Ftg. 2. The effect of vartous concentrattona of AC-568 on MEL cells 
dtfferenttation and growth. The percent of hemoglobm-producmg 
cells (B+ cells) and concentrattnn of hke cells m the culture were 
analyzed at day 4 (A) and day I3 (B) subsequent to AC-568 apphca- 
tton. Day 4 (prevtous to differenttation) and day 12 (up to 80% of 
dtfferentiated cells) are both 4 days after the cells were diluted to then 
imttal concentratton (1x10’ cells/ml). The concentrattons of 200 ,uM 
and abobe are toxtc to cells, and hence do not appear m (B). 
cedure designed ‘unwashed cells’ 75% of the culture was 
replaced every two or three days with fresh tyrphostin- 
containing medium. This was the routine procedure we 
used for screening the effect of various tyrphostins. In 
a different procedure, designed ‘washed cells’ 25% of the 
culture were sedimented and resuspended with fresh 
AG568-containing medium. Fig. 4B shows that while 
AG568 used in the ‘unwashed cells’ procedure induces 
differentiation of MEL cells. it fails to induce differenti- 
ation in the alternative procedure. We therefore sus- 
pected that the tyrphostin induces the production of a 
differentiating factor. Thus we collected the medium at 
least two days after the last medium renewal and treated 
MEL cells previously not exposed to tyrphostin. As 
shown in Fig. 5, the supernatant (S.N.) of cells treated 
with 50 PM AG568 using the ‘unwashed cells’ proce- 
dure induces the differentiation of MEL cells. In con- 
trast, the supernatant of cells treated using the ‘washed 
cells’ procedure does not induce differentiation. The 
supernatant from cells which were treated using the 
‘unwashed cells’ procedure but without tyrphostin also 
3.3. AG568 khibits the t~wsinr phosphor~dution of‘pp97 
it1 intact MEL crlls 
Using antiphosphotyrosine antibodies, a number of 
tyrosine phosphorylated proteins could be identified in 
Western blots of lysates of MEL cells (Fig. 6A). The 
tyrosine phosphorylation of one band, pp97. dimin- 
ished following treatment with AG568. at a concentra- 
tion effective in inducing cell differentiation concomi- 
tant to growth arrest. The 170 and 53 kDa bands were 
not significantly affected by AG568. The onset of inhi- 
bition of pp97 tyrosine phosphorylation precedes 
growth arrest (Fig. 6B). AG775, a highly potent tyr- 
phostm in vitro [ 131, neither induces MEL cells to differ- 
entiate (Table I) nor does it inhibit the tyrosine phos- 
phorylation of any of the above bands (Fig. 6A). Simi- 
larly, other tyrphostins potent in vitro but ineffective in 
inducing MEL cell differentiation (Table I) also fail to 
block pp97 phosphorylation. 
4. DISCUSSION 
In this study we present evidence that the tyrphostin 
AG568. a specific inhibitor for tyrosine kinases. induces 
erythroid differentiation of MEL cells (Fig. l-5) follow- 
ing the inhibition of tyrosine phosphorylation of at least 
one protein, pp97. Other potent tyrphostins. such as 
AG775 (Table I). which do not induce cell differentia- 
tion also fail to inhibit tyrosine phosphorylation of pro- 
teins observed in the phosphorylation blot (Fig. 6). This 
untreated cells AG-568 (50 yM) 
treated cells. 
Ftg. 3. MEL cells treated with AG-568. MEL cells were treated for 
12 days with 50 PM AG-568. A sample from the culture was stamed 
with benridme. and photographed at magmtude xX0. 
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Fig 4. AG568 Induced production of a putative differentiatton factor. 
MEL cells were treated with 50 PM AG-568 using two alternative 
procedures as schematically described in (A). In the procedure desig- 
nated ‘unwashed cells’ 75% of the culture was removed every 2 days 
and tyrphostm-containing medium m the same volume was added. In 
the procedure designated ‘washed cells’ the cells were sedtmented. the 
old medium was removed completely, and the cells were resuspended 
with fresh medium containing tyrphostin As control the cells were 
treated using ‘unwashed cells’ procedure, but in the absence of tyr- 
phostin. (B) shows that cells treated by the ‘unwashed cells’ procedure 
were differentiated, whereas cells whose supernatant was washed were 
not. 
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Fig. 5 The effect of supernatant from cells treated with AG-568 on 
the dtfferentiation of untreated MEL cells. MEL cells were treated 
wtth supernatant from cells treated with AG568 as described in Ftg. 
4, two days after AG-568 application. The supernatant ofboth washed 
and unwashed cells contains the same amount of AC-568 left over 
from previous treatments As acontrol we have used supernatant from 
cells treated with the ‘unwashed cells’ procedure m the same condt- 
tions. but without tyrphostin. 
result suggests a correlation between the inhibition of 
tyrosine phosphorylation in intact MEL cells and the 
onset of differentiation. AG568 seems to be a selective 
tyrosine kinase blocker since it inhibits the tyrosine 
phosphorylation of pp97, but not of other proteins in 
A 
2oo- - - - f- ppl80 
+ PQ97 
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Fig. 6. AG-568 inhibits pp97 phosphorylatton in intact MEL cells. 
80- 
prior to differentiation. (A) The tyrosine phosphorylation levels m 
MEL cells was analyzed by anttphosphotyrosine antibodies. For a S 60. 
control we have used AG-775, non-differentiated but in vitro effecttve 
8 
tyrphostin, or medium containmg the tyrphostm solvent alone. (B) 
Kinetics of mhibition of the tyrosine phosphorylatton by AG-568. The 
G 40. 
% 
intensity of the phosphotyrosine-contammg bands was analyzed using 
a Macintosh scanner. The value measured for pp97 was standardized 
e 
to compare with the AG-568 uninfluenced band, ~~180, in each lane. 
do s 
The percent of inhibition was calculated compared to the intensity of __---__----_----_ 0,’ “‘_ ‘.““‘I +.“““c .’ 
standardized pp97 of the untreated cells. Benzidine-positive cells (B+ .1 1 10 100 
cells) were analyzed as described. time (hrs.) 
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intact MEL cells. AG568 was also found to induce 
erythroid differentiation of the K.562 cell line concomi- 
tantly with the inhibition of p2 10h’r-uh’ tyrosine phospho- 
rylation in intact cells [14]. One of the derivatives of 
AG568, AGll12, was found to be even more effective 
in inducing K562 differentiation and in inhibiting tyro- 
sine phosphorylation of ~210~‘~-~~’ [14]. Interestingly. 
AGlll2 was ineffective in the MEL cell system (Table 
I, data not shown) suggesting that the latter is a more 
selective tyrphostin towards K562 cells and the 
p210 h’r-‘rh’ kinase. The differentiation of MEL cells be- 
gins 2-5 days after, subsequent to AG568 application. 
Fig. 1 shows that after 80% of the cells differentiated, 
a significant fraction of the differentiated cells die. This 
result suggests that AG568 induces terminal differentia- 
tion of MEL cells. Kinetic and dose-response analysis 
demonstrates a correlation between growth arrest and 
differentiation (Figs. 1 and 2). Furthermore, growth 
arrest is induced by AG568 concentration. well below 
its toxic level (Fig. 2). Thus, growth arrest is not a result 
of general toxicity of AG568, but rather a consequence 
of the differentiation process. 
AG568 was also found to inhibit the tyrosine phos- 
phorylation of ~210 h’r-uh’ in intact K562 cells after one 
hour of application [14]. In MEL cells, the inhibition of 
pp97 phosphorylation is a secondary event induced by 
this tyrosine kinase blocker, probably due to the inhibi- 
tion of important but rare tyrosine kinase(s). 
We have found that MEL cells treated with AG568, 
produce a putative differentiation agent. We cannot 
eliminate, at this stage, the possibility that the differen- 
tiating agent is a cell-mediated modification of AG568 
which elevates the activity of the original compound. 
The appearance of AG568-mediated differentiation 
agent, is probably part of the differentiation process 
induced by AG568 and requires a more elaborate inves- 
tigation. We would like to suggest that the production 
of this agent occurs as a result of the tyrosine kinase 
inhibitory activity of AG568 where the inhibition of 
pp97 phosphorylation (Fig. 6) may be involved. 
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